Loading…
CIK 0001587114 • 6 13F filings • May 15, 2025 – Aug 14, 2026
Import this data to Google Sheets with:
=jivedata("ecor1-capital-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ALKERMES PLC | SHS | $15.0M | 0.7% | 500,000 SH | New |
| ANAPTYSBIO INC | COM | $241.3M | 11.6%Prev: 25.9% | 7,880,094 SH | Decreased |
| APELLIS PHARMACEUTICALS INC | COM | $78.0M | 3.7% | 3,447,156 SH | New |
| AQUESTIVE THERAPEUTICS INC | COM | $14.7M | 0.7% | 2,625,000 SH | New |
| ATARA BIOTHERAPEUTICS INC | COM NEW | $8.2M | 0.4%Prev: 0.9% | 573,183 SH | Decreased-978,817 SH |
| AVIDITY BIOSCIENCES INC | COM | $33.3M | 1.6% | 765,000 SH | New |
| BRIDGEBIO ONCOLOGY THERAPEUT | COM NEW ADDED | $32.7M | 1.6% | 2,823,126 SH | New |
| CENTESSA PHARMACEUTICALS PLC | SPONSORED ADS | $13.3M | 0.6% | 550,000 SH | New |
| COMPASS PATHWAYS PLC | SPONSORED ADS | $1.5M | 0.1% | 265,137 SH | New |
| CRINETICS PHARMACEUTICALS IN | COM | $178.6M | 8.6% | 4,288,120 SH | New |
| CRISPR THERAPEUTICS AG | NAMEN AKT | $90.0M | 4.3%Prev: 3.7% | 1,389,276 SH | Increased |
| ETON PHARMACEUTICALS INC | COM | $44.1M | 2.1%Prev: 3.8% | 2,030,544 SH | Decreased-141,394 SH |
| GALAPAGOS NV | SPON ADR | $57.7M | 2.8% | 1,667,119 SH | New |
| IMMUNOME INC | COM | $47.8M | 2.3% | 4,079,415 SH | New |
| JAZZ PHARMACEUTICALS PLC | SHS USD | $224.9M | 10.8% | 1,706,469 SH | New |
| KURA ONCOLOGY INC | COM | $7.7M | 0.4% | 872,500 SH | New |
| MADRIGAL PHARMACEUTICALS INC | COM | $34.4M | 1.7% | 75,000 SH | New |
| MBX BIOSCIENCES INC | COM | $37.2M | 1.8%Prev: 1.0% | 2,123,604 SH | Increased+1,735,104 SH |
| METSERA INC | COM | $14.2M | 0.7% | 271,529 SH | New |
| NEUROGENE INC | COM | $22.0M | 1.1%Prev: 1.9% | 1,271,342 SH | Decreased |
| NUVATION BIO INC | *W EXP 02/10/202 | $3.6M | 0.2% | 963,333 SH | New |
| ORIC PHARMACEUTICALS INC | COM | $80.7M | 3.9%Prev: 3.5% | 6,728,116 SH | Increased |
| PEPGEN INC | COM | $3.7M | 0.2% | 800,000 SH | New |
| PRIME MEDICINE INC | COM | $8.6M | 0.4% | 1,543,326 SH | New |
| SURROZEN INC | *W EXP 08/01/203 | $859K | 0.0%Prev: 0.0% | 66,665 SH | Increased+62,221 SH |
| TANGO THERAPEUTICS INC | COM | $89.3M | 4.3% | 10,630,736 SH | New |
| UNIQURE NV | SHS | $232.8M | 11.2% | 3,988,971 SH | New |
| VOYAGER THERAPEUTICS INC | COM | $3.1M | 0.2% | 670,303 SH | New |
| XENCOR INC | COM | $72.1M | 3.5% | 6,144,767 SH | New |
| ZYMEWORKS INC | COM | $392.3M | 18.8%Prev: 29.2% | 22,970,388 SH | Decreased |
| 13F-HR |
| 0000935836-26-000415 |
| $2.06B |
| View |
| Aug 14, 2025 | Q2 2025 | 13F-HR | 0000935836-25-000506 | $1.69B | View |
| May 15, 2026 | Q1 2026 | 13F-HR | 0000935836-26-000270 | $2.36B | View |
| May 15, 2025 | Q1 2025 | 13F-HR | 0000935836-25-000338 | $1.69B | View |